Literature DB >> 10404082

Relationship between Fas-ligand expression on carcinoma cell and cytotoxic T-lymphocyte response in lymphoepithelioma-like cancer of the stomach.

T Kume1, K Oshima, Y Yamashita, T Shirakusa, M Kikuchi.   

Abstract

The Fas/Fas-ligand (Fas-L) system is involved in the induction of apoptosis and mediates T-cell cytotoxicity. We investigated the Fas/Fas-L system and cytotoxic T lymphocytes (CTLs) in 30 lymphoepithelioma-like cancer of the stomach (LECS) in order to understand the immune evasion of the tumor cells. Epstein-Barr virus (EBV) was detected in 15 cases in 30 LECSs. The expressions of Fas and Fas-L in tumor cells, and TIA-1, CD4, CD8 and CD56 in lymphocytes were examined by immunohistochemical staining. Apoptosis of tumor cells and lymphocytes was detected by the terminal deoxynucleotidyl-mediated dUTP-nick end labeling method (TUNEL). Expression of Fas and Fas-L was detected in tumor cells in 10 and 17 LECS, respectively. CTL consisted predominantly of CD8 (CD8(+) > CD4(+)), whereas natural killer (NK) cells were detected in 4 cases only. In Fas-L-positive tumors, the TIA-1-positive lymphocyte count was significantly lower (p < 0.05) and the number of apoptotic lymphocytes was significantly higher (p < 0.05) than in Fas-L-negative cases. The number of TIA-1-positive lymphocytes in EBV(+) cases was significantly higher than that in the EBV(-) tumors (p < 0.05). The number of apoptotic tumor cells in EBV(+) tumors was significantly lower than in EBV(-) cases (p < 0.01). Our results suggest that in LECS, tumor cells expressing Fas-L may evade the immune attack by killing lymphocytes through the Fas/Fas-L system. However, in EBV(+) LECS tumors, our results indicate that a high number of CTL is associated with a reduction in the number of apoptotic tumor cells. Our findings indicate that the Fas/Fas-L system plays a role in immune evasion of tumor cells in EBV(+) tumors. Int. J. Cancer (Pred. Oncol.) 84:339-343, 1999. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10404082     DOI: 10.1002/(sici)1097-0215(19990820)84:4<339::aid-ijc1>3.0.co;2-2

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Helicobacter pylori modulates lymphoepithelial cell interactions leading to epithelial cell damage through Fas/Fas ligand interactions.

Authors:  J Wang; X Fan; C Lindholm; M Bennett; J O'Connoll; F Shanahan; E G Brooks; V E Reyes; P B Ernst
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  Expression of RCAS1 and FasL in human trophoblasts and uterine glands during pregnancy: the possible role in immune privilege.

Authors:  K Ohshima; M Nakashima; K Sonoda; M Kikuchi; T Watanabe
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

3.  Molecular mechanism about lymphogenous metastasis of hepatocarcinoma cells in mice.

Authors:  L Hou; Y Li; Y H Jia; B Wang; Y Xin; M Y Ling; S Lü
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

4.  Clinical significance of Fas and FasL protein expression in gastric carcinoma and local lymph node tissues.

Authors:  Qian Li; Jie Peng; Xin-Hua Li; Ting Liu; Qing-Chun Liang; Gui-Ying Zhang
Journal:  World J Gastroenterol       Date:  2010-03-14       Impact factor: 5.742

Review 5.  Therapeutic vaccination with tumor cells that engage CD137.

Authors:  Karl Erik Hellstrom; Ingegerd Hellstrom
Journal:  J Mol Med (Berl)       Date:  2003-02-08       Impact factor: 4.599

6.  The expression of hTERT mRNA and cellular immunity in gastric cancer and precancerosis.

Authors:  Xi-Xian Yao; Lei Yin; Zhong-Cheng Sun
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

7.  Significance of Fas and FasL protein expression in cardiac carcinoma and local lymph node tissues.

Authors:  Yin Li; Da-Fu Xu; Dong Jiang; Jun Zhao; Jin-Feng Ge; Shi-Ying Zheng
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

8.  Interleukin-1beta expression in human gastric carcinoma with Epstein-Barr virus infection.

Authors:  Ja-Mun Chong; Kazuya Sakuma; Makoto Sudo; Toshio Osawa; Etsuko Ohara; Hiroshi Uozaki; Junji Shibahara; Kenji Kuroiwa; Shin-Ichi Tominaga; Yoshitaka Hippo; Hiroyuki Aburatani; Nobuaki Funata; Masashi Fukayama
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

Review 9.  Restoring Lost Anti-HER-2 Th1 Immunity in Breast Cancer: A Crucial Role for Th1 Cytokines in Therapy and Prevention.

Authors:  Nadia F Nocera; M Catherine Lee; Lucy M De La Cruz; Cinthia Rosemblit; Brian J Czerniecki
Journal:  Front Pharmacol       Date:  2016-10-06       Impact factor: 5.810

10.  Apoptosis-Related Gene-Mediated Cell Death Pattern Induces Immunosuppression and Immunotherapy Resistance in Gastric Cancer.

Authors:  Xiaolu Yuan; Jun Zhou; Liping Zhou; Zudong Huang; Weiwei Wang; Jiasheng Qiu; Qiangbang Yang; Chaohao Zhang; MingHui Ma
Journal:  Front Genet       Date:  2022-07-05       Impact factor: 4.772

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.